The Indefinite Delivery Contract awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc. provides various vaccines and medical supplies to support DLA operations. Per the multiple task order descriptions, DMS is contracted to deliver yellow fever (YF-VAX 1), hepatitis A (HAVRIX), typhoid (Typhim VI), and asthma (DULERA) vaccines. Additional products include local anesthetic (Polocaine 2%) and syringes in single dose vials and other packaging. Performance locations are DMS's facility in Park Ridge, Illinois.
Task orders range from $186 to $499,999 in potential value, utilizing firm fixed price and covering periods from January 2023 to December 2025. No set-asides were specified. As the DLA centrally manages medical logistics for the Department of Defense worldwide, this IDV and subsequent orders ensure military readiness by maintaining stockpiles of critical medicines and inoculations through DMS's prime vendor services. The contract vehicle and orders appear tailored to streamline procurement of specialized pharmaceutical products in support of the DLA's integrated supply chain mission.
Generated 1/4/24, 9:36 PM